Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis.

Cahue S, Sharma L, Dunlop D, Ionescu M, Song J, Lobanok T, King L, Poole AR.

Osteoarthritis Cartilage. 2007 Jul;15(7):819-23. Epub 2007 Mar 6.

2.

Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.

Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM.

J Rheumatol. 2005 May;32(5):896-902.

PMID:
15868627
3.

Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis.

Conrozier T, Poole AR, Ferrand F, Mathieu P, Vincent F, Piperno M, Verret C, Ionescu M, Vignon E.

Clin Exp Rheumatol. 2008 May-Jun;26(3):430-5.

PMID:
18578964
4.

Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.

Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD.

Arthritis Rheum. 2002 Oct;46(10):2613-24.

5.

Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study.

Cibere J, Zhang H, Garnero P, Poole AR, Lobanok T, Saxne T, Kraus VB, Way A, Thorne A, Wong H, Singer J, Kopec J, Guermazi A, Peterfy C, Nicolaou S, Munk PL, Esdaile JM.

Arthritis Rheum. 2009 May;60(5):1372-80. doi: 10.1002/art.24473.

6.

Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis.

Mazzuca SA, Poole AR, Brandt KD, Katz BP, Lane KA, Lobanok T.

J Rheumatol. 2006 Jun;33(6):1147-51.

PMID:
16652436
7.

Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies.

Conrozier T, Ferrand F, Poole AR, Verret C, Mathieu P, Ionescu M, Vincent F, Piperno M, Spiegel A, Vignon E.

Osteoarthritis Cartilage. 2007 Apr;15(4):462-7. Epub 2006 Oct 18.

8.

Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.

Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD.

Arthritis Rheum. 2005 Mar;52(3):885-91.

9.

Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.

Verstappen SM, Poole AR, Ionescu M, King LE, Abrahamowicz M, Hofman DM, Bijlsma JW, Lafeber FP; Utrecht Rheumatoid Arthritis Cohort Study group (SRU).

Arthritis Res Ther. 2006;8(1):R31. Epub 2006 Jan 10.

10.

Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.

Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB.

Arthritis Rheum. 2006 Aug;54(8):2496-504.

11.

Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study.

Hunter DJ, Li J, LaValley M, Bauer DC, Nevitt M, DeGroot J, Poole R, Eyre D, Guermazi A, Gale D, Felson DT.

Arthritis Res Ther. 2007;9(5):R108.

12.

Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis.

Rego-Pérez I, Fernández-Moreno M, Deberg M, Pértega S, Fenández-López C, Oreiro N, Henrotin Y, Blanco FJ.

Ann Rheum Dis. 2010 May;69(5):910-7. doi: 10.1136/ard.2009.117416. Epub 2009 Nov 23.

PMID:
19934106
13.

Greater Mechanical Loading During Walking Is Associated With Less Collagen Turnover in Individuals With Anterior Cruciate Ligament Reconstruction.

Pietrosimone B, Blackburn JT, Harkey MS, Luc BA, Hackney AC, Padua DA, Driban JB, Spang JT, Jordan JM.

Am J Sports Med. 2016 Feb;44(2):425-32. doi: 10.1177/0363546515618380. Epub 2015 Dec 18.

PMID:
26684662
14.

Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure.

Berry PA, Maciewicz RA, Wluka AE, Downey-Jones MD, Forbes A, Hellawell CJ, Cicuttini FM.

Ann Rheum Dis. 2010 Oct;69(10):1816-22. doi: 10.1136/ard.2009.124420. Epub 2010 Jun 15.

PMID:
20551154
15.

Effects of exercise level on biomarkers in a rat knee model of osteoarthritis.

Yamaguchi S, Aoyama T, Ito A, Nagai M, Iijima H, Zhang X, Tajino J, Kuroki H.

J Orthop Res. 2013 Jul;31(7):1026-31. doi: 10.1002/jor.22332. Epub 2013 Mar 11.

17.

Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy.

Mullan RH, Matthews C, Bresnihan B, FitzGerald O, King L, Poole AR, Fearon U, Veale DJ.

Arthritis Rheum. 2007 Sep;56(9):2919-28.

18.

Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.

Niki Y, Takeuchi T, Nakayama M, Nagasawa H, Kurasawa T, Yamada H, Toyama Y, Miyamoto T.

PLoS One. 2012;7(5):e37447. doi: 10.1371/journal.pone.0037447. Epub 2012 May 21.

19.
20.

A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.

Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P.

Rheumatology (Oxford). 2007 Jun;46(6):938-43. Epub 2007 Mar 26.

PMID:
17387119

Supplemental Content

Support Center